China Pharma Holdings (CPHI) EPS (Basic) Growth (5y) (2016 - 2026)
China Pharma Holdings (CPHI) EPS (Basic) Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.93% |
| Dec 31, 2025 | 54.02% |
| Sep 30, 2025 | 57.11% |
| Jun 30, 2025 | -25.24% |
| Mar 31, 2025 | 49.84% |
| Dec 31, 2024 | 68.18% |
| Sep 30, 2024 | 39.61% |
| Jun 30, 2024 | 37.85% |
| Mar 31, 2024 | 31.41% |
| Dec 31, 2023 | 47.00% |
| Sep 30, 2023 | 32.70% |
| Jun 30, 2023 | 23.70% |
| Mar 31, 2023 | 2.64% |
| Dec 31, 2022 | 40.31% |
| Sep 30, 2022 | 20.69% |
| Jun 30, 2022 | 18.99% |
| Mar 31, 2022 | 0.41% |
| Dec 31, 2021 | -0.60% |
| Sep 30, 2021 | 14.85% |
| Jun 30, 2021 | 20.31% |